Beacon Pointe Advisors’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,111
| Closed | -$11.1K | – | 1198 |
|
|
2022
Q4 | $11.1K | Sell |
4,111
-56
| -1% | -$151 | ﹤0.01% | 1057 |
|
|
2022
Q3 | $17K | Hold |
4,167
| – | – | ﹤0.01% | 990 |
|
|
2022
Q2 | $28K | Hold |
4,167
| – | – | ﹤0.01% | 1031 |
|
|
2022
Q1 | $49K | Buy |
+4,167
| New | +$49K | ﹤0.01% | 1172 |
|
|
2021
Q4 | – | Sell |
-889
| Closed | -$22K | – | 1013 |
|
|
2021
Q3 | $22K | Buy |
889
+189
| +27% | +$4.68K | ﹤0.01% | 893 |
|
|
2021
Q2 | $44K | Buy |
700
+20
| +3% | +$1.26K | ﹤0.01% | 823 |
|
|
2021
Q1 | $83K | Buy |
680
+52
| +8% | +$6.35K | 0.01% | 520 |
|
|
2020
Q4 | $72K | Sell |
628
-129
| -17% | -$14.8K | ﹤0.01% | 498 |
|
|
2020
Q3 | $90K | Sell |
757
-581
| -43% | -$69.1K | 0.01% | 392 |
|
|
2020
Q2 | $166K | Buy |
+1,338
| New | +$166K | 0.02% | 383 |
|